Kliničke studije za Lupus u državi Tennessee
13 studija za Lupus traži sudionike na lokacijama u državi Tennessee.
Gradovi u državi Tennessee
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50001, Jackson
- Sl0044 50693, Murfreesboro
U tijeku regrutacijaFaza 3
Od 16 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06617325A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
U tijeku regrutacijaFaza 2
Od 18 do 74 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- West Tennessee Research Institute, Jackson
- Shelby Research LLC, Memphis
U tijeku regrutacijaFaza 3
Od 12 do 100 godina · Oba spola · Ažurirano 1. lis 2026. · NCT06133972A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Memphis
- Research Site, Memphis
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- West Tennessee Research Institute, Jackson
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- West Tennessee Research Institute - Jackson /ID# 284561, Jackson
U tijeku regrutacijaFaza 1
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07607964A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Murfreesboro Medical Clinic, Murfreesboro
U tijeku regrutacijaOpažajna studija
Od 16 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07175285A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)
- Private Practice - Dr. Ramesh C. Gupta /ID# 275826, Memphis
U tijeku regrutacijaFaza 1
Od 18 do 75 godina · Oba spola · Ažurirano 10. kol 2026. · NCT06977724A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Memphis
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 27. srp 2026. · NCT07260877A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
- Regional One Health, Memphis
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 5. lip 2026. · NCT066133602-HOBA in Systemic Lupus Erythematosus
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaFaza 2
Od 18 godina i više · Žene · Ažurirano 22. svi 2026. · NCT07225543A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Regional One Health, Memphis
U tijeku regrutacijaFaza 1
Od 12 do 70 godina · Oba spola · Ažurirano 22. svi 2026. · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaOpažajna studija
Od 18 do 110 godina · Oba spola · Ažurirano 15. tra 2026. · NCT05934149Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.